Literature DB >> 23836217

MSCs: science and trials.

Willem E Fibbe, Francesco Dazzi, Katarina LeBlanc.   

Abstract

Mesh：

Year:  2013        PMID： 23836217     DOI： 10.1038/nm.3222

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

1.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Authors:  Katarina Le Blanc; Ida Rasmusson; Berit Sundberg; Cecilia Götherström; Moustapha Hassan; Mehmet Uzunel; Olle Ringdén
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

2.  Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.

Authors:  Ganesh Suntharalingam; Meghan R Perry; Stephen Ward; Stephen J Brett; Andrew Castello-Cortes; Michael D Brunner; Nicki Panoskaltsis
Journal:  N Engl J Med       Date:  2006-08-14       Impact factor: 91.245

3.  The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells.

Authors:  Simon Jones; Nicole Horwood; Andrew Cope; Francesco Dazzi
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

4.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

Authors:  Massimo Di Nicola; Carmelo Carlo-Stella; Michele Magni; Marco Milanesi; Paolo D Longoni; Paola Matteucci; Salvatore Grisanti; Alessandro M Gianni
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

5.  The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine.

Authors:  Paolo Bianco; Xu Cao; Paul S Frenette; Jeremy J Mao; Pamela G Robey; Paul J Simmons; Cun-Yu Wang
Journal:  Nat Med       Date:  2013-01-07       Impact factor: 53.440

6.  Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.

Authors:  Peter Connick; Madhan Kolappan; Charles Crawley; Daniel J Webber; Rickie Patani; Andrew W Michell; Ming-Qing Du; Shi-Lu Luan; Daniel R Altmann; Alan J Thompson; Alastair Compston; Michael A Scott; David H Miller; Siddharthan Chandran
Journal:  Lancet Neurol       Date:  2012-01-10       Impact factor: 44.182
  6 in total
  9 in total

Review 1.  Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions.

Authors:  Suzanne E Berry
Journal:  Stem Cells Transl Med       Date:  2014-11-12       Impact factor: 6.940

2.  Reply to MSCs: science and trials.

Authors:  Paolo Bianco
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 3.  Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities.

Authors:  Jacques Galipeau; Luc Sensébé
Journal:  Cell Stem Cell       Date:  2018-06-01       Impact factor: 24.633

4.  Therapeutic implications of transplanted-cell death.

Authors:  Zachary W Wagoner; Weian Zhao
Journal:  Nat Biomed Eng       Date:  2021-05       Impact factor: 25.671

Review 5.  Mesenchymal stem cells: immune evasive, not immune privileged.

Authors:  James A Ankrum; Joon Faii Ong; Jeffrey M Karp
Journal:  Nat Biotechnol       Date:  2014-02-23       Impact factor: 54.908

6.  Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match.

Authors:  Jayeeta Giri; Jacques Galipeau
Journal:  Blood Adv       Date:  2020-05-12

7.  Hydroxyethyl Chitosan-Reinforced Polyvinyl Alcohol/Biphasic Calcium Phosphate Hydrogels for Bone Regeneration.

Authors:  Lei Nie; Yaling Deng; Pei Li; Ruixia Hou; Amin Shavandi; Shoufeng Yang
Journal:  ACS Omega       Date:  2020-05-06

Review 8.  Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells.

Authors:  Peter Deng; Audrey Torrest; Kari Pollock; Heather Dahlenburg; Geralyn Annett; Jan A Nolta; Kyle D Fink
Journal:  Neural Regen Res       Date:  2016-05       Impact factor: 5.135

9.  Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogramming.

Authors:  Silvia Selleri; Panojot Bifsha; Sara Civini; Consiglia Pacelli; Mame Massar Dieng; William Lemieux; Ping Jin; Renée Bazin; Natacha Patey; Francesco M Marincola; Florina Moldovan; Charlotte Zaouter; Louis-Eric Trudeau; Basma Benabdhalla; Isabelle Louis; Christian Beauséjour; David Stroncek; Françoise Le Deist; Elie Haddad
Journal:  Oncotarget       Date:  2016-05-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.